FDA Provides Emergency Authorization to Fast and Inexpensive COVID-19 Test

The United States Food and Drug Administration (FDA) has granted Abbott Laboratories emergency authorization for its $5, 15-minute COVID-19 test. The antigen test is point-of-care, meaning that no lab or equipment is needed to process the test results. Tested patients will learn whether they are infected with the novel coronavirus within 15 minutes. Abbott plans on manufacturing millions of tests beginning in September with the hopes of making at least 50 million in October. Such a rapid and affordable test could make a significant difference in isolating those who are infected and slowing the rapid spread of COVID-19.  Read more here.